Delivery Order SPE2DB22D2206-SPE2DB25FGT26
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $4,719.34. The contract type is a delivery order with an ultimate completion date of October 7, 2025, and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $9.44K delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity: 7) under a firm fixed-price contract, with an ultimate completion date of October 9, 2025. This non-set-aside competitive award was issued on September 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral medication used to prevent cytomegalovirus infection in...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract contains no set-aside designation and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for 480 mg tablets of Prevymis (letermovir), an antiviral medication used in transplant patients. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Prevymis 480 mg tablets (7-count units). The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Prevymis (letermovir) 120 mg pellet packets in quantities of 30 units. The contract, valued at $5,599.72, is structured as a firm fixed price delivery order with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This is a firm fixed-price contract with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGT26Delivery Order
The Defense Logistics Agency awarded a $9.4K delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 16, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.9M through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA covering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. Prevymis (letermovir), an antiviral medication used primarily in immunocompromised populations, represents one of the specialized pharmaceutical commodities that AmerisourceBergen supplies through its federal contract vehicles to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 4/25/25 |